Wound healing activities and potential of selected african medicinal plants and their synthesized biogenic nanoparticles by Tyavambiza, Caroline et al.
plants
Review
Wound Healing Activities and Potential of Selected African
Medicinal Plants and Their Synthesized Biogenic Nanoparticles
Caroline Tyavambiza 1,2 , Phumuzile Dube 2 , Mediline Goboza 2, Samantha Meyer 1,
Abram Madimabe Madiehe 2,3 and Mervin Meyer 2,*


Citation: Tyavambiza, C.; Dube, P.;
Goboza, M.; Meyer, S.; Madiehe,
A.M.; Meyer, M. Wound Healing
Activities and Potential of Selected
African Medicinal Plants and Their
Synthesized Biogenic Nanoparticles.
Plants 2021, 10, 2635. https://
doi.org/10.3390/plants10122635
Academic Editors: Ki Hyun Kim and
Franklin Gregory
Received: 30 September 2021
Accepted: 10 November 2021
Published: 30 November 2021
Publisher’s Note: MDPI stays neutral
with regard to jurisdictional claims in
published maps and institutional affil-
iations.
Copyright: © 2021 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).
1 Phytotherapy Research Group, Department of Biomedical Sciences, Cape Peninsula University of Technology,
P.O. Box 1906, Bellville, Cape Town 7535, South Africa; carolinetyavambiza@gmail.com (C.T.);
meyers@cput.ac.za (S.M.)
2 DSI/Mintek Nanotechnology Innovation Centre (NIC), Biolabels Node, Department of Biotechnology,
University of the Western Cape, Private Bag X17, Bellville, Cape Town 7535, South Africa;
phumuedube@gmail.com (P.D.); 3990471@myuwc.ac.za (M.G.); amadiehe@uwc.ac.za (A.M.M.)
3 Nanobiotechnology Research Group, Department of Biotechnology, University of the Western Cape,
Private Bag X17, Bellville, Cape Town 7535, South Africa
* Correspondence: memeyer@uwc.ac.za; Tel.: +27-21-9592032
Abstract: In Africa, medicinal plants have been traditionally used as a source of medicine for
centuries. To date, African medicinal plants continue to play a significant role in the treatment of
wounds. Chronic wounds are associated with severe healthcare and socio-economic burdens despite
the use of conventional therapies. Emergence of novel wound healing strategies using medicinal
plants in conjunction with nanotechnology has the potential to develop efficacious wound healing
therapeutics with enhanced wound repair mechanisms. This review identified African medicinal
plants and biogenic nanoparticles used to promote wound healing through various mechanisms
including improved wound contraction and epithelialization as well as antibacterial, antioxidant
and anti-inflammatory activities. To achieve this, electronic databases such as PubMed, Scifinder®
and Google Scholar were used to search for medicinal plants used by the African populace that
were scientifically evaluated for their wound healing activities in both in vitro and in vivo models
from 2004 to 2021. Additionally, data on the wound healing mechanisms of biogenic nanoparticles
synthesized using African medicinal plants is included herein. The continued scientific evaluation of
wound healing African medicinal plants and the development of novel nanomaterials using these
plants is imperative in a bid to alleviate the detrimental effects of chronic wounds.




Wounds are defined as injury to living tissue which leads to the disruption of its
normal anatomical structure and function [1]. They arise due to physical, chemical, ther-
mal, microbial or immunological damage to the tissue [2]. Regardless of the aetiology
and type, wounds can cause damage to the tissue and disrupt the surrounding environ-
ment. The damage can affect the integrity of the skin epithelial layer and can also extend
into the subcutaneous tissue disrupting other structures such as tendons, muscles and
nerves [1,3]. Failure of wounds to heal normally leads to chronic wounds. Chronic wounds
are a silent epidemic claiming the lives of many individuals worldwide. In the past decade,
it has been estimated that 6 million people suffer from chronic wounds worldwide [2,4–6].
Wounds have a significant negative impact on the economic and social lives of patients
and their families. They cause severe pain, physical disability such as immobility and loss
of function, loss of self-esteem, depression and anxiety as well as premature death [7,8].
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Not only do wounds affect the patients’ social life, they also pose a great financial burden
on patients and the healthcare systems. Chronic wounds consume a great amount of
healthcare resources around the world [8].
Chronic wounds are predominantly a condition of the elderly, however, their preva-
lence is expected to increase in all age groups because of the increase in conditions that
impede wound healing, such as diabetes, obesity and vascular disorders [9,10]. The high
and increasing prevalence of these conditions continues to increase the global burden
of chronic wounds. Unfortunately, to our knowledge, there are no statistical records on
the prevalence of chronic wounds in Africa.
1.2. Classification of Wounds
Wounds can be classified depending on their healing time. Acute wounds heal timely,
following the normal wound healing process. They result in the restoration of anatomical
and functional integrity of the normal tissue [11]. On the other hand, chronic wounds
require prolonged time to heal, and they do not progress through the normal stages
of wound healing [12]. Given their complexity, chronic wounds tend to fall into four
categories, namely pressure ulcers, venous ulcers, diabetic ulcers and arterial insufficiency
ulcers [8,13].
Wounds can also be classified as open (those associated with disruption and disconti-
nuity of the skin) or closed (when there is damage to the underlying tissue but the skin
is intact) [12]. Open wounds can be further classified as incisions (cut by a sharp object
such as a scalpel), lacerations (tear like wounds), abrasions (scraping of the outer skin
layer), puncture wounds, penetration wounds (caused by an object entering or exiting
the skin surface) and gunshot wounds. Most open wounds are often associated with
a wide range of bacterial and fungal infections as the underlying tissues are exposed to
the outside environment [5,12]. The challenge of antimicrobial resistance in treating these
infections increases the complications and burden of these wounds [14,15]. Repetitive
trauma, which is common in diabetic foot ulcers, can also delay or even stop the wound
healing process [16]. Closed wounds include contusions (caused by a blunt force trauma
that damages tissue under the skin), haematomas (accumulation of blood under skin due
to a damaged blood vessel) and crush injuries (occurs when great external force is applied
on the skin over a long period of time) [17].
1.3. Phases of Wound Healing
Wound healing is a complex physiological process which aims to restore the anatom-
ical structure and function of an injured tissue [18]). This process is divided into four
integrated phases, namely haemostasis, inflammation, proliferation and tissue remodelling.
Haemostasis involves vascular constriction and coagulation. Platelets attach to exposed
collagen surfaces and extracellular matrix leading to the activation of the coagulation
cascade and clot formation, thereby preventing blood loss [19,20]. This process is mediated
by growth factors released by platelets such as Epidermal growth factor (EGF), Platelet-
derived growth factor (PDGF), Transforming growth factor-beta (TGF-β) and Fibroblast
growth factor (FGF). These growth factors together with some cytokines play a vital role in
the movement of monocytes and neutrophils to the wound site initiating the inflammatory
phase [5,21]. During inflammation, neutrophils and monocytes penetrate the wound site.
Neutrophils, which are the first leukocytes to infiltrate the wound site, eliminate invading
microorganisms through phagocytosis and release reactive oxygen species and proteolytic
enzymes [22,23]. Neutrophils also release IL-8 aiding chemotaxis which attracts monocytes
and other cells to the wound site [19]. Monocytes then differentiate into macrophages
which continue the process of phagocytosis and cleansing of the wound. They also initiate
the development of granulation tissue and angiogenesis by releasing various growth (FGF,
EGF, TGF-b, and PDGF) and cytokines (IL-1 and IL-6) [24,25].
The proliferation phase comes immediately after the cleansing of the wound and then
the repair process (building of new tissue). This phase is characterized by the formation
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of granulation tissue, angiogenesis, wound contraction and epithelialization [26]. It in-
volves the activity of many cells including fibroblasts, keratinocytes, and endothelial cells.
Granulation involves the deposition of newly synthesized extracellular matrix composed
of collagen, fibrin and fibronectin which replaces the damaged tissue [27]. Angiogenesis
by endothelial cells ensures sufficient supply of nutrients and oxygen to the granula-
tion tissue [28]. Fibroblasts and myofibroblasts cause the wound to contract by pulling
the wound edges together. Subsequently keratinocytes migrate over the granulation tissue
from the wound edges towards the center to cover the wound and protect the underlying
issue [21,29]. The tissue remodeling phase (last phase) occurs after the wound has closed.
This phase aims to achieve maximum tensile strength and flexibility of the new tissue.
However, the wound never achieves the same level of tensile strength as the normal tissue.
Remodeling and reorganization of collagen fibres occurs, resulting in the formation of
cross-linkages which reduces scar thickness. The level of vascularity decreases as the scar
matures [30,31]. The cells playing a part in wound repair are removed by apoptosis as they
are no longer needed [32].
1.4. Risk Factors and Conditions Associated with Wound Healing
The wound healing process is not only complex but also fragile, as it is susceptible
to numerous interruptions and failure. Various factors can affect one or more phases
of wound healing as well as its sequence and time frame, leading to the impairment
of this process. These factors delay wound healing resulting in poor outcomes thereby
increasing the patient morbidity and mortality [26]. The risk factors of wound healing
are classified into local and systemic. Systemic factors affect the general health of an
individual, which influences their ability to heal normally. These factors include age, stress,
chronic diseases (such as diabetes mellitus, hepatic and renal failure), obesity, alcoholism,
medication and immunocompromising conditions (such as cancer and AIDS) [15]. Local
factors are those that directly influence the characteristics of the wound itself. These
include infection, oxygenation, venous insufficiency and the presence of foreign material
in the wound. All these factors are related, usually systemic factors act through the local
factors in affecting wound healing [33].
Infections are one of the most common complications of wounds, as they disrupt
the normal wound healing process, leading to the development of chronic wounds. Fre-
quently isolated bacterial species in wounds include Staphylococcus aureus, Pseudomonas
aeruginosa and β-hemolytic streptococci [15,34]. The loss of skin integrity as a result of the in-
jury enables pathogens to invade the wound site and cause infections. Bacterial invasion
affects all stages of wound healing, particularly the inflammatory phase. This phase plays
an important role in microbial clearance and wound cleansing. However, in the pres-
ence of an infection, inflammation is prolonged due to the increased microbial load and
incomplete microbial clearance [35]. Bacterial toxins decrease chemotaxis and increase
the secretion of pro-inflammatory cytokines such as IL-1 and TNF-α. This further prolongs
the inflammation, causing the wound to enter a chronic state [25,34]). The continuous
inflammatory phase increases the presence of neutrophils, which will lead to the degra-
dation of the extracellular matrix and loss of important wound healing growth factors
(TGF-β and PDGF) [36]. The increase in neutrophils will also increase the production of
reaction oxygen species (ROS). The ROS are essential in cellular metabolism, however,
when produced in excess they cause cellular damage and further affect the healing of
the wound [11]. In the treatment of wounds, it is therefore imperative for a wound healing
agent to have antimicrobial, anti-inflammatory and antioxidant activities as this will aid in
the healing of the wound.
1.5. Conventional Treatment and Management of Wounds
The care and management of wounds is of great importance in wound healing, as it
ensures and aids proper wound healing. The aim of good wound management is to provide
and maintain a warm, moist, non-toxic environment which supports natural wound healing.
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Poorly managed wounds can lead to the development of non-healing chronic wounds [37].
Hygiene is one of the important factors in wound management as it minimizes the risk
of wound infections. Wounds undergo debridement before the application of topical
treatments such as antimicrobial and silver wound dressings, silver sulfadiazine creams
and oils and sprays. Debridement is the removal of necrotic tissue from the affected area
in-order to promote wound healing [20]. Topical therapies are the first line of treatment
of wounds. After assessment, and if healing is not achieved, advanced wound therapies
are then used. The most common advanced wound therapies include negative pressure
wound therapy, administration of growth factors, hyperbaric oxygen and skin grafts [8].
These therapies are very costly, hence, not all individuals can access them, especially
in poor resource countries. They are also associated with severe complications such as
bleeding, infection, barotrauma and oncogenesis [38–40]. Although these therapies are
available, the burden of chronic wounds is increasing. The search for new affordable and
easily accessible wound treatment drugs and therapies is therefore vital. One reliable source
of drug discovery is medicinal plants as they have been used traditionally for many years
in the treatment of many human ailments. It has been reported that 25% of modern drugs
were derived from plants [41,42]. Nanomaterials synthesized from medicinal plants were
also shown to be beneficial in wound healing. In this article, we will review different wound
healing mechanisms of African medicinal plants as well as those of biogenic nanoparticles
synthesized using African medicinal plants. To achieve this, electronic databases such as
PubMed, Scifinder® and Google Scholar were used in the search. The African medicinal
plants and their biogenic nanoparticles were evaluated for their wound healing activities
in both in vitro and in vivo models from 2004 to 2021.
2. African Medicinal Plants in the Treatment of Wounds
The African continent is well known for an immense biodiversity distribution with
nearly 45,000 different plant species of which about 5000 species have been used as tradi-
tional medicines [5]. Throughout history, medicinal plants have been used exclusively in
the treatment and management of different diseases, especially in poor communities. It is
documented that 80% of the African populace rely on medicinal plants as their primary
source of medication as medicinal plants are more affordable, easily accessible and are
associated with fewer side effects when compared to conventional medicines [43]. Medici-
nal plants are a good source of compounds which could serve as leads for drug discovery
for wound healing [44]. The wound healing activities displayed by medicinal plants are
attributed to the presence of bioactive chemicals such as phenols, alkaloids, triterpenes,
and flavonoids. In wound healing, these bioactive compounds have been reported to
have antioxidant and antimicrobial activities, improve collagen deposition and increase
the proliferation of both fibroblasts and keratinocytes [5,45]. In most instances, the wound
healing process progresses naturally. However, the presence of an infection can cripple
the healing process by lengthening the inflammatory phase, disturbing the normal clotting
mechanisms, disrupting leukocyte function and angiogenesis [46]. Thus, the antimicrobial
effects exhibited by many plants explain the significant roles they display in the healing
of wounds. On the other hand, phenolic compounds were reported to play an important
role in the healing of wounds because of their antioxidant effect against free radicals which
negatively influence the progression of wound healing [47]. Various reports have provided
information on plants used in Africa for the treatment of wounds. Some of these plants are
listed in Table 1 below.
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Table 1. Wound healing activities of selected African medicinal plants.
Plant Name Family Plant Part Used Mode of Wound Healing Reference
Acacia senegal Mimosae Root Antimicrobial [48]
Aloe ferox Asphodelaceae Leaf gel Antioxidant, anti-inflammatory and antibacterialactivities [49,50]
Aloe vera Asphodelaceae Leaf gel Enhance mature granulation, antioxidant,anti-inflammatory and antibacterial activities [45]
Aspalathus linearis Fabaceae Leaves Antioxidant, anti-inflammatory and antibacterialactivities [51]
Argyreia nervosa Convolvulaceae Leaves and roots Antibacterial and anti-inflammatory [52,53]
Boerhavia diffusa Nyctaginaceae Whole plants Increased myoblast migration, antioxidant [44]
Boophone disticha Amaryllidaceae Bulb Antimicrobial, anti-inflammatory [53,54]
Bridelia ferruginea Combretaceae Leaf Stimulation of fibroblasts [55]
Bulbine frutescens Asphodelaceae Gel sap Improvement of wound contraction [56]
Catharanthus roseus Apocynaceae Leaf Improved wound contraction, decreased epithelizationperiod and antibacterial activities [57]
Centella asiatica Umbelliferae Leaves Increased cellular proliferation, angiogensis collagensynthesis, antioxidant and anti-inflammatory [58,59]
Cotyledon orbiculata Crassulaceae Leaf gel Antioxidant, anti-inflammatory and antibacterialactivities [60–63]
Ficus asperifolia Moraceae Bark Stimulation of fibroblasts, antioxidant [46]
Gossypium arboreum Malvaceae Leaf Stimulation of fibroblasts, antioxidant [46]
Gunnera perpensa Gunneracea Root Antioxidant and antibacterial activities [64,65]
Gymnosporia senegalensis Celestraceae Leaf, bark, roots Anti-inflammatory and antimicrobial activities [66]
Haemanthus coccineus Amaryllidaceae Bulb Anti-inflammatory [58,67]
Maytenus heterophylla Celastraceae Crushed leaves Anti-inflammatory and antimicrobial activities [68]
Merwilla natalensis Asparagaceae Fresh and burnt bulbscales Anti-inflammatory and antimicrobial activities [50]
Ocimum gratissimum L. Lamiaceae Leaf Antibacterial and activities [55,69]
Parkia biglobosa Fabaceae Stem Stimulation of fibroblasts and antibacterial activity [55]
Sutherlandia frutescens Fabaceae Leaves Antibacterial [70]
Tecoma capensis Bignoniaceae Bark Improved wound contraction and re-epithelialization [71]
Terminalia sericea Combretaceae Bark Antioxidant, anti-inflammatory and antibacterialactivities [64,72]
Vernonia amygdalina Asteraceae Leaf Improved wound contraction and re-epithelialization [73]
3. Nanotechnology as a Wound Healing Intervention
Medicinal plants have been incorporated in the field of nanotechnology in a bid to
enhance the activity of the plants. Different nanoparticles including silver [63,70,74,75],
gold [76,77], titanium dioxide [78] and selenium [79,80] have been successfully synthesized
using plants.
Silver containing wound therapies have a long history of use in the treatment of
chronic wounds. Silver releasing agents are known to inhibit the manifestation of a va-
riety of microorganisms including fungi, Gram-positive and Gram-negative bacteria on
wounds [81]. This is due to silver interfering with the electron transport system or binding
to and inhibiting DNA replication of the microbes [82]. Additionally, these silver thera-
peutics display low systemic toxicity as they can be neutralized by anions in body fluids.
Some of the most widely used silver based wound dressings, such as Askina Calgitrol Ag®,
Aquacel® Ag Dressing, 3M Tegaderm Alginate Ag Silver Dressing and Systagenix Silvercel
antimicrobial alginate dressing, contain silver alginates, whilst common topical agents such
as Silvadene, Thermazene® and SSD Cream® contain silver sulfadiazine [83–88]. Certain
dressings like Aquacel® Ag Dressing may cause skin irritation and allergies [86]. The more
extensive methods of chronic wound treatment such as negative pressure wound therapy,
administration of growth factors, hyperbaric oxygen and skin grafts have been reported to
be costly, unsafe and detrimental to surrounding healthy tissues [39]. Hence, novel wound
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healing strategies with increased efficacy and limited side effects are constantly being devel-
oped. In this line, nanotechnology has the potential to address these matters of concern, as
it is providing novel materials that exhibit enhanced size-dependent properties [27,89,90].
Nanotechnology has played a notable role in the delivery of improved methods for dis-
ease diagnostics and therapeutics. To date, about 51 nanopharmaceuticals synthesized from
liposomes, polymers, nanocrystals, proteins, micelles and inorganic reducing agents have
been approved by the US Federal Drug Agency and are available in clinical practices, whilst
several nanomedicines are undergoing clinical trials [91,92]. Examples include the widely
used ActicoatTM Flex 3 and Acticoat©, which are silver nanoparticle-based products that
promote wound healing whilst reducing pain and infection at the wound site [93,94]. Sil-
ver nanoparticles have been shown to promote wound healing with improved cosmetic
appearance. The activity has been attributed to their antimicrobial properties, reduction in
wound inflammation and modulation of fibro-genic cytokines. Tian et al. (2007) reported
that silver nanoparticles had an increased healing rate compared to silver sulfadiazine,
the standard treatment for burn wounds [95]. Despite their popularity, the prolonged use
of these silver based wound therapies may slow the wound healing process due to epithe-
lial and fibroblast cytotoxicity and cause negative cosmetic effects such as argyria. Other
nanoparticles such as gold, zinc oxide and selenium have also been used to promote wound
healing [96,97]. Thermo-responsive gels containing gold nanoparticles displayed antimi-
crobial and wound healing properties as shown by in vitro, in vivo and histopathological
assays [98]. Low concentrations of gold nanoparticles, 34 nm in size, significantly promoted
the proliferation of keratinocytes, which are important in wound closure [99]. This proved
the great efficiency and potential of the gold nanoparticles as wound therapeutics and
a probable alternative to autografts.
3.1. Biogenic Nanoparticles in Wound Healing
Although several chemical and physical synthesis methods for the production of
nanoparticles are known and used, the synthesis of nanoparticles using biological models
has several advantages over these methods. This is due to the fact that nanoparticle
synthesis using physio-chemical approaches utilizes organic solvents and toxic reducing
agents whilst producing hazardous waste-products [100]. The biologically synthesized
nanoparticles possess a great advantage where applicability in industrial and human
health care products is concerned. Numerous biological approaches which employ different
natural resources such as plants, microorganisms and algae in the synthesis of nanoparticles
are available [77]. Although microorganisms are widely used to reduce metallic salt
solutions to form corresponding nanoparticles, the process uses toxic and costly reactants
that result in an unsuitable platform for biocompatible synthesis [27]. On the other hand,
plants are readily used to synthesize nanoparticles as they are easily accessible and can
promote rapid nanoparticle synthesis [101]. Bioactive plant phytochemicals (alkaloids,
phenolic acids, polyphenols, saponins, proteins, sugars, and terpenoids) are believed
to have significant roles in the synthesis of nanoparticles [102]. They are involved in
the reduction of metallic ions and also act as capping agents that stabilize the synthesized
nanoparticles [103].
The unique features of synthesized nanoparticles such as large surface area to volume
ratio allow them to bind and deliver small-sized beneficial compounds to target sites.
The ability of biogenic nanoparticles to combine with bioactive drugs and other useful
compounds can result in a synergistic effect, which further enhances their efficiency and
effectiveness. Combining Urtica dioica silver nanoparticles and the antibiotics Amoxicillin,
Amikacin, Kanamycin, Tetracycline and Cefotaxime showed a synergistic inhibitory activ-
ity against S. aureus, Staphylococcus epidermidis, Escherichia coli, Klebsiella pneumoniae, Bacillus
cereus, Bacillus subtilis, Serratia marcescens and Salmonella typhimurium. This was shown by
a 0.1- to 17.8-fold increase in the zones of inhibition [104]. Many polymers including chi-
tosan, hyaluronan, pyridoxine and collagen have been combined with silver nanoparticles
to form silver nanocomposites with enhanced wound healing properties [97]. The combi-
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nation of silver nanoparticles with tetracycline was shown to significantly improve wound
healing and wound infection control in Albino mice [105].
Given the history and benefits of medicinal plants found on the African continent,
combining these plants and nanotechnology can lead to the development of important
nanomedicines. Though some of the medicinal plants are not native to the African conti-
nent, several are found and harvested in one or more African countries. The bio-synthesized
nanoparticles may potentially improve wound healing efficacy, exhibit better antimicrobial
activity and/or promote accelerated wound closure compared to the raw materials and
current treatments as shown in Table 2. The enhanced activity could be attributed to
the expected increase in the stability of bioactive phytochemicals within the nanoparticles
and the large surface area of the synthesized nanoparticles [75,106,107].
Table 2. Biogenic nanoparticles synthesized using African medicinal plants exhibiting wound healing activities.
Plant Name Nanoparticle Type Particle Size Experimental Outcomes Reference
Azadirachta indica Silver
60–85 nm
(a) In diabetic rats, the nanoparticles show increased wound
contraction and accelerated wound healing compared to
the control and the drug alone.
[108]
33 nm
(b) Synthesized silver nanoparticles displayed enhanced
antibacterial and antioxidant effects when compared to
the leaf extracts alone. The nanoparticle infused PF127
hydrogel improved the wound contraction rate in mice.
[109]
30 nm
(c) The wound beds where the nanoparticles were topically
applied showed no microbial growth, haemorrhage, or
formation of pus throughout treatment. The nanoparticle
treated female BALB/c mice showed better
wound-healing capacity when compared to control group
animals.
[74]
Cassia auriculata L. Silver 15–90 nm
Nanoparticles showed an increased percentage of wound
contraction in both excision and incision wound models when





(a) When the silver nanoparticles were topically applied on
open wounds, the treated animals exhibited better wound
healing activity and decreased inflammation compared to
those treated with the respective aqueous plant extract.
[111]
30 nm
(b) Silver nanoparticle treated wounds on female BALB/c
mice showed decreased irritation with greater wound
healing capacity when compared to the positive control.
[74]
Curcuma longa L. Silver 15–40 nm Synthesized nanoparticles increased fibroblast cell proliferationand migration indicating effective wound healing. [112]
Falcaria vulgaris Silver 40–45 nm
The nanoparticles promoted the healing of cutaneous wounds on
male rats by decreasing the wound area and increasing wound
contracture, antimicrobial and antioxidant activity,
fibroblast-fibrocyte ratio and macrophages at the wound site
when compared to the activity of F. vulgaris extracts and
tetracycline.
[113]
Mimosa pudica silver 7.63 nm
Biosynthesized nanoparticles incorporated in an electrospun
polyvinyl alcohol (PVA) improved keratinocyte migration when
compared to the activity of PVA alone.
[114]
Moringa oliefera Titanium dioxide 100 nm
The synthesized nanoparticles promoted significant wound
closure in Albino rats when compared to a standard commercial
wound therapeutic.
[75]
Prosopis juliflora Silver 10–20 nm The percentage of wound healing was increased forthe nanoparticles when compared to that of Povidine-iodine. [115]
Woodfordia fruticosa Gold 13 nm
Topical application of the synthesized nanoparticles on excised
wounds on Wistar albino rat models resulted in the effective
prevention of microbial adhesion and accelerated wound closure
in comparison to the activity of 5% Povidone-iodine.
[116]
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3.2. Biological Nanoparticles with Potential Wound Healing Properties
Delonix elata copper oxide nanoparticles (36 nm in size) applied on human wounds
after anal rectum surgery caused rapid wound epithelialization [117]. Nanoparticle treated
wounds also showed a weaker inflammatory response probably resulting from cytokine
modulation. An association between wound healing and the anti-inflammatory and/or
antioxidant activities of therapeutics has been established. Anti-inflammatory agents
are important in controlling inflammation whilst antioxidants address oxidative stress at
the site of the wound thereby accelerating wound healing [118]. Both these properties
have also been reported to decrease the production of pus at the wound site. Numerous
nanoparticles synthesized using medicinal plants found on the African continent have been
shown to exhibit either antioxidant and/or anti-inflammatory activity (Table 3), classifying
them as potential wound healing therapies.
Table 3. Biogenic nanoparticles synthesized using African medicinal plants with bioactivities that promote wound healing.
Plant Name Nanoparticle Size Anti-InflammatoryActivity
Antioxidant
Activity Reference
Allium ampeloprasum Silver 8 nm - Yes [119]
Aloe vera Selenium 7–48 nm - Yes [80]
Areca catechu Silver 18.2–24.3 nm - Yes [120]
Artocarpus altilis Silver 38 nm - Yes [121]
Cola nitida Silver 12–80 nm - Yes [122]
Cotyledon orbiculata Silver 20–60 nm Yes - [63]
Cuminum cyminum Silver - Yes - [123]
Garcinia indica Gold 20–30 nm - Yes [124]
Garcinia indica Silver 5–30 nm - Yes [125]
Helicteres isora Silver 38.23 nm - Yes [126]
Hypoxis hemerocallidea Gold 27 nm Yes - [127]
Kalanchoe pinata Zinc oxide 24 nm Yes - [128]
Nigella sativa Silver 25.2 nm Yes Yes [129]
Oxalis corniculata Silver 30 nm - Yes [130]
Phoenix dactylifera Zinc sulphide <70 nm - Yes [131]
Terminalia bellirica Silver 11 nm Yes Yes [132]
Terminalia bentazoe Silver 7 nm Yes Yes [132]
Terminalia catappa Silver 10 nm Yes Yes [132]
Terminalia mellueri Silver 10 nm Yes Yes [132]
Zingiber officinale Selenium 100–150 nm - Yes [79]
The potential of biogenic nanoparticles, especially those synthesized using African
medicinal plants has not been fully explored. In many instances biogenic nanomateri-
als have been proven effective for most biomedical applications. Numerous nano-based
medicines have been approved by the FDA for use while many others are on trial. It is there-
fore of great importance to investigate all wound healing activities of biogenic nanoparticles
as this might lead to the discovery of efficacious wound healing therapeutics.
4. Conclusions and Recommendations
A thorough and effective wound healing process is crucial to the well-being and
socio-economic state of patients. The complexity of a typical healing process is due to
the various components involved at both cellular and subcellular levels. Although clas-
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sic topical wound therapeutics including medicinal plants and silver sulfadiazine are
still common among the African populace, the prevalence of chronic wounds remains
high. Henceforth, current technologies such as nanotechnology should focus mainly on
the molecular and cellular aspects of wound healing in the development of therapeutic
interventions. Considering that silver nanoparticle impregnated wound dressings are
slowly becoming a standard in wound and burn therapy, the discovery of the full potential
of nanomedicine is necessary. Unlike conventional physio-chemical methods, the green
synthesis of nanoparticles using known medicinal plants is a non-toxic approach in the pro-
duction of biocompatible nanoparticles. It is also cost effective, making it affordable for
low resource African countries to utilize these strategies to develop alternative treatments.
Given the great potential of biogenic nanoparticles in various biomedical applications
and medicinal plants in drug discovery, it is imperative that widely used wound heal-
ing medicinal plants native to the African continent be incorporated in nanomaterials.
However, the scarcity of scientific evidence reporting the wound healing activities of
biogenic nanoparticles synthesized using these African medicinal plants is concerning.
Green nanotechnology still has a vast selection of raw materials still to be explored on
the African continent. Therefore, the development of novel nanomaterials exhibiting
impressive wound healing activity and the further understanding of the mechanisms
underlying their beneficial properties is important for future research.
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